TokenPost·
Sonoma Pharmaceuticals Posts $7.17 Million in Fiscal Q2 Revenue
The company recorded a basic and diluted GAAP net loss per share of $0.01 for the quarter ended Sept. 30, 2026.
More news
- TokenPostGraco and Bank of America Agree to $600 Million Accelerated Share Repurchase
- TokenPostAnza Sets Dec. 14 Start for Agave v4.5 Feature Activations
- TokenPostJupiterExchange Amplifies Dhanda’s $4 Billion to $5 Billion Tokenization Utility Estimate
- TokenPostTidewater Sets 2027 Revenue Target of Up to $1.75 Billion
- TokenPostJBS Expects 2027 Capital Spending to Fall by About $500 Million
- TokenPostB. Riley Raises WhiteHorse Finance Rating to Buy on Review Upside